|
__________________________________________________________________ About Us _ News Services Education Publications Jobs Contact Us |
|
|||||
|
About Us
|
Experience The first CRO to conduct clinical trials to GCP standard in Russia, Ukraine, and Georgia, EVIDENCE was also the first to conduct a multinational study in Russia. In addition, we participated in the large-scale multinational cardiovascular studies that achieved breakthrough results. These results were subsequently published in such international publications, as JAMA, the Lancet, the New England Journal of Medicine and the European Heart Journal. The following areas were covered:
EVIDENCE currently manages over 350 active investigative sites; and
over the years has recruited more than 28,000 patients. Our recruiting rates
have been constantly highest among CRO participating in the same studies,
with the highest quality of CRF completion. EVIDENCE and our clinical sites
have received positive audit results from our study sponsors, as well as
independent auditors, including the AAC Consulting Group (US), AAI/L.A.B.
(Germany), BQA and CBA (UK). EVIDENCE has a proven track record in conducting phase I-IV clinical studies in:
|
||||||